The treatment of osteoarthritis
- PMID: 1576063
- PMCID: PMC1381323
- DOI: 10.1111/j.1365-2125.1992.tb04052.x
The treatment of osteoarthritis
Abstract
1. The treatment of osteoarthritis is currently purely symptomatic. To enable rational therapy, careful clinical assessment is necessary to identify the origin of symptoms. Often, effective therapy can result from a biomechanical approach such as surgery, orthotics, physiotherapy and dieting. If drugs are required, there is little evidence that the current over-reliance on non-steroidal anti-inflammatory drugs (NSAIDs) is justified. Full dose regular paracetamol should be the first line of analgesic therapy. In the majority of patients, simple analgesics are probably as effective as NSAIDs. If NSAIDs are used it is necessary to review regularly their use and to be aware of potential toxicity. 2. Many alternative strategies of pain management such as topical preparations, intra-articular steroid injections, acupuncture, radiosynovectomy, transcutaneous nerve stimulation and anti-depressants, may be effective but their precise place in the armamentarium is not yet fully established. 3. The realisation that osteoarthritis is not a passive 'wear and tear' phenomenon but an active process that may be potentially modified, has led to interest in 'chondroprotective' agents, which may beneficially affect the osteoarthritic process. To date there are no convincing data available that such agents are, in fact, chondroprotective in humans.
Similar articles
-
Osteoarthritis 1991. Current drug treatment regimens.Drugs. 1991 Feb;41(2):193-201. doi: 10.2165/00003495-199141020-00005. Drugs. 1991. PMID: 1709850 Review.
-
Pharmacotherapy and osteoarthritis.Baillieres Clin Rheumatol. 1997 Nov;11(4):749-68. doi: 10.1016/s0950-3579(97)80008-8. Baillieres Clin Rheumatol. 1997. PMID: 9429735 Review.
-
Osteoarthritis in the aged. Epidemiological issues and optimal management.Drugs Aging. 1995 May;6(5):409-20. doi: 10.2165/00002512-199506050-00007. Drugs Aging. 1995. PMID: 7647428 Review.
-
Optimising pain control in osteoarthritis.Practitioner. 2010 Dec;254(1735):23-6, 2-3. Practitioner. 2010. PMID: 21306035
-
[The role of nonsteroidal anti-inflammatory drugs, oral preparations, and viscosupplementation in conservative treatment of cartilage lesions].Acta Orthop Traumatol Turc. 2007;41 Suppl 2:48-53. Acta Orthop Traumatol Turc. 2007. PMID: 18180584 Review. Turkish.
Cited by
-
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.Drugs Aging. 2016 Feb;33(2):75-85. doi: 10.1007/s40266-016-0347-4. Drugs Aging. 2016. PMID: 26849131 Free PMC article. Review.
-
Determination of the miRNA profile of extracellular vesicles from equine mesenchymal stem cells after different treatments.Stem Cell Res Ther. 2025 Apr 5;16(1):162. doi: 10.1186/s13287-025-04287-5. Stem Cell Res Ther. 2025. PMID: 40188160 Free PMC article.
-
Stereoisomers and drug toxicity. The value of single stereoisomer therapy.Drug Saf. 1993 Feb;8(2):149-59. doi: 10.2165/00002018-199308020-00005. Drug Saf. 1993. PMID: 8452656 Review.
-
Drug treatment of rheumatic diseases in the 1990s. Achievements and future developments.Drugs. 1997 Mar;53(3):337-48. doi: 10.2165/00003495-199753030-00001. Drugs. 1997. PMID: 9074838 Review.
-
A randomised controlled trial of the clinical and cost-effectiveness of ultrasound-guided intra-articular corticosteroid and local anaesthetic injections: the hip injection trial (HIT) protocol.BMC Musculoskelet Disord. 2018 Jul 18;19(1):218. doi: 10.1186/s12891-018-2153-0. BMC Musculoskelet Disord. 2018. PMID: 30021588 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical